Document is current
Any future updates will be listed below
-
Authors
La Porta, Caterina A. M. https://orcid.org/0000-0002-3010-8966
Garrone, Ornella https://orcid.org/0000-0001-7359-5410
Merlano, Marco
Zapperi, Stefano https://orcid.org/0000-0001-5692-5465
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (28402)
- License Information
-
More Information
Article History
Received: 26 October 2024
Accepted: 3 September 2025
First Online: 3 October 2025
Competing interests
: C.A.M.L.P. and S.Z. are listed as inventors of Italian and US patent related to the present work, concerning a method to screen breast cancer patients using transcriptomic data and Boolean networks and owned by Complexdata SRL (Patent status: granted. Date of application: 13/12/2019. Application number: 102019000023946. US patent: US20230145332A1). S.Z. and C.A.M.P.L. hold 7.36% and 14.73% shares of Complexdata SRL, respectively. O.G. is member of Advisory Boards of MSD, Pfizer, Astra Zeneca, Daiichi-Sankyo, Gielad, Lilly, received honororaria from Novartis, Lilly, Pfizer, Exact Sciences and travel expenses from Ipsen, Gilead, Novartis.
